Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa (RDEB) Nonsense Mutation Patients
Clinical trial NCT02698735 · COMPLETED
Trial details
- NCT number
- NCT02698735
- Sponsor
- University of Southern California
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-25
- Primary completion
- 2017-03-31
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.